Brief: Oncozenge Has Been Approved For Listing On Nasdaq First North Growth Market

Moberg Pharma AB (publ)

10/02/2021 13:38

Feb 10 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * ONCOZENGE HAS BEEN APPROVED FOR LISTING ON NASDAQ FIRST NORTH GROWTH MARKET
    * MOBERG PHARMA AB (PUBL) -  ONCOZENGE FIRST DAY OF TRADING IN ONCOZENGE'S SHARES WILL BE ON
FRIDAY, FEBRUARY 12, 2021

Source text for Eikon:  ID:nWkrbXDmG8 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))